Abstract:Background: Voxel-based morphometry studies have repeatedly highlighted the presence of distributed gray matter changes in schizophrenia, but to date, it is not clear if clinically useful prognostic information can be gleaned from structural imaging. The suspected association between gray matter volume (GMV) and duration of psychotic illness, antipsychotic exposure, and symptom severity also limits the prognostic utility of morphometry. We address the question of whether morphometric information from patients with drug-naive first-episode psychosis can predict the linear trajectory of symptoms following early antipsychotic intervention using a longitudinal design. Method: Sixty-two first-episode, drug-naive patients with schizophrenia underwent brain magnetic resonance imaging scans at baseline, treated with antipsychotics, and rescanned after 1-year follow-up. Positive and Negative Syndrome Scale (PANSS) was used to assess their clinical manifestations. A multivariate approach to detect covariancebased network-like spatial components [Source Based Morphometry (SBM)] was performed to analyze the GMV. Paired t tests were used to study changes in the loading coefficients of GMV in the spatial components between two time points. The reduction in PANSS scores between the baseline (T0) and 1-year follow-up (T1) expressed as a ratio of the baseline scores (reduction ratio) was computed for positive, negative, and disorganization symptoms. Separate multiple regression analyses were conducted to predict the longitudinal change in symptoms (treatment response) using the loading coefficients of spatial components that differed between T0 and T1 with age, gender, duration of illness, and antipsychotic dose as covariates. We also tested the putative "toxicity" effects of baseline symptom severity on the GMV at 1 year using multiple regression analysis. Results: Of the 30 spatial components of gray matter extracted using SBM, loading coefficients of anterior cingulate cortex (ACC), insula and inferior frontal gyrus (IFG), superior temporal gyrus (STG), middle temporal gyrus (MTG), precuenus, and dorsolateral prefrontal cortex (DLPFC) reduced with time in patients. Specifically, the lower volume of insula and IFG at baseline predicted a lack of improvement in positive and disorganization symptoms. None of the symptom severity scores (positive, negative, or disorganization) at baseline independently predicted the reduced GMV at 1 year. Conclusions: The baseline deficit in a covariance-based network-like spatial component comprising of insula and IFG is predictive of the clinical course of schizophrenia. We do not find any evidence to support the notion of symptoms per se being neurotoxic to gray matter tissue. If judiciously combined with other available predictors of clinical outcome, multivariate morphometric information can improve our ability to predict prognosis in schizophrenia.

The associations between duration of untreated psychosis, growth factors, and neurocognition in patients with drug-naïve schizophrenia

[An MRI Study of the Relationship Between Duration of Untreated Psychosis and Morphology of Cerebral Cortex in First-episode Schizophrenia].

Correlation between duration of untreated psychosis and long-term prognosis in chronic schizophrenia

The influence of duration of unmedicated psychosis on the neurocognitive functions of drug-naive and first episode schizophrenia

Duration of Untreated Psychosis is Associated with Temporal and Occipitotemporal Gray Matter Volume Decrease in Treatment Naïve Schizophrenia

Factors Related to Duration of Untreated Psychosis of First Episode Schizophrenia Spectrum Disorder.

Effect of time and duration of untreated psychosis on cognitive and social functioning in Chinese patients with first-episode schizophrenia: A 1-year study.

Time Consumption in Mind-Reading: A Potentially Important Factor for Social Cognition Assessment in Early Psychosis

Duration of Untreated Prodromal Psychosis among Individuals with Clinical High Risk for Psychosis.

The clinical significance of duration of untreated psychosis: an umbrella review and random‐effects meta‐analysis

Influence of duration of untreated psychosis on auditory P300 in drug-naive and first-episode schizophrenia.

Duration of untreated psychiatry affecting white matter integrity in first-episode medication-free patients with schizophrenia

Cognitive Impairment in First-Episode Drug-Naïve Patients with Schizophrenia: Relationships with Serum Concentrations of Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor.

Prognostic Utility of Multivariate Morphometry in Schizophrenia.

Neurocognitive deficits in first-episode schizophrenic patients and their first-degree relatives

Duration of untreated illness and its influential factors in schizophrenia

Neurocognition and NMDAR co-agonists pathways in individuals with treatment resistant first-episode psychosis: a 3-year follow-up longitudinal study

Relationship Between Duration of Untreated Prodromal Symptoms and Symptomatic and Functional Recovery

Correlation study of brain-derived neurotrophic factor, EEG γ activity and cognitive function in first-episode schizophrenia

Impact of duration of untreated psychosis in short-term response to treatment and outcome in antipsychotic naïve first-episode psychosis

Duration of Untreated Prodromal Symptoms in a Chinese Sample at a High Risk for Psychosis: Demographic, Clinical, and Outcome